Increased peripheral blood pro-inflammatory/cytotoxic lymphocytes in children with bronchiectasis by Hodge, Greg et al.
RESEARCH ARTICLE
Increased Peripheral Blood Pro-
Inflammatory/Cytotoxic Lymphocytes in
Children with Bronchiectasis
G. Hodge1*, J. W. Upham2, A. B. Chang3,4, K. J. Baines5,6, S. T. Yerkovich7, S. J. Pizzutto3,
S. Hodge1
1 Lung Research, Hanson Institute and Dept. Thoracic Medicine, Royal Adelaide Hospital, Adelaide,
Australia, 2 The University of Queensland School of Medicine, Princess Alexandra Hospital, Brisbane,
Queensland, Australia, 3 Child Health Division, Menzies School of Health Research, Darwin, Northern
Territory, Australia, 4 Department of Respiratory and Sleep Medicine, Lady Cilento Children’s Hospital,
Queensland University of Technology, Children’s Health Queensland, South Brisbane, Queensland
Australia, 5 Dept. Respiratory and Sleep Medicine, Hunter Medical Research Institute, Newcastle, New
South Wales, Australia, 6 University of Newcastle, New South Wales, Australia, 7 The University of
Queensland School of Medicine and Prince Charles Hospital, Brisbane, Queensland, Australia
* greg.hodge@health.sa.gov.au
Abstract
Objective
Bronchiectasis (BE) in children is common in some communities including Indigenous chil-
dren in Australia. Relatively little is known about the nature of systemic inflammation in
these children, especially the contribution of specific pro-inflammatory and cytotoxic lym-
phocyte subsets: T-cells, natural killer (NK) cells and NKT-like cells. We have shown that
these cells produce increased cytotoxic (granzyme b and perforin) and inflammatory (IFNγ
and TNFα) mediators in several adult chronic lung diseases and hypothesised that similar
changes would be evident in children with BE.
Methods
Intracellular cytotoxic mediators perforin and granzyme b and pro-inflammatory cytokines
were measured in T cell subsets, NKT-like and NK cells from blood and bronchoalveolar
samples from 12 children with BE and 10 aged-matched control children using flow
cytometry.
Results
There was a significant increase in the percentage of CD8+ T cells and T and NKT-like sub-
sets expressing perforin/granzyme and IFNγ and TNFα in blood in BE compared with con-
trols. There was a further increase in the percentage of pro-inflammatory cytotoxic T cells in
Indigenous compared with non-Indigenous children. There was no change in any of these
mediators in BAL.
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Conclusions
Childhood bronchiectasis is associated with increased systemic pro-inflammatory/cytotoxic
lymphocytes in the peripheral blood. Future studies need to examine the extent to which
elevated levels of pro-inflammatory cytotoxic cells predict future co-morbidities.
Introduction
Bronchiectasis (BE) is a progressive disease of the airways characterised by chronic infection
and associated inflammation. Although uncommon in children living in developed countries,
BE is common in some communities such as in Indigenous children in Alaska (USA) and Aus-
tralia [1]. In these populations where indigenous groups experienced poorer housing and
sociodemographic circumstances, BE is present in one in every 63–68 children and often begins
very early in life [2] where prematurity and increased frequency and earlier onset of acute
lower respiratory infections is more common than in non-Indigenous groups [2]. Poor and
inadequate treatment leads to loss of lung function and subsequent reduction in life expectancy
[2], whereas effective management of BE has been shown to reduce morbidity [3].
The potential links between long-term inflammation and co-morbidities such as the develop-
ment of dysplasia and cancer [4,5], microbial infection [6] and cardiovascular disease [7] have
been well described. In this regard there have been reports of increases in systemic markers of
inflammation during stable phases of BE in adult patients [8], and BE has been shown to be an
independent risk factor for atherosclerosis [9] cardiovascular disease, which is 1.3 times more
common in Indigenous people, and osteoporosis, which is 1.8 times more common in Indigenous
males than their non-Indigenous counterparts [10]. The lower sociodemographic conditions
experienced by Indigenous groups is likely to contribute to a higher incidence of systemic disease,
including the increased rate of BE as well as increased colonisation of the lower airway with
microorganisms including non-typeableHaemophilus influenzae (NTHi) and S. pneumoniae.
Our group has reported increased production of Th1 pro-inflammatory cytokines IFN-γ and
TNF-α by CD8+ T cells in both peripheral blood and lungs [11] and higher levels of the cytotoxic
mediators granzyme b and perforin in peripheral blood NKT-like and NK cells in adult inflamma-
tory lung disease including chronic obstructive pulmonary disease (COPD), severe asthma and
bronchiolitis obliterans syndrome following lung transplantation [12–15]. However relatively little
is known about the nature of systemic inflammation in BE. Some limited information suggests
systemic cytokine over-production and neutrophilic inflammation in BE [16], but it is not known
whether the systemic inflammation also involves lymphocyte populations in the circulation.
We hypothesized that these markers of systemic inflammation may also be present in chil-
dren with BE, especially in Indigenous children where BE is generally more severe when diag-
nosed [1]. To investigate this hypothesis, we determined whether T, NKT-like and NK cells
from children with BE express increased levels of cytotoxic mediators, perforin and granzyme
b and pro-inflammatory cytokines in peripheral blood and airways compared with aged
matched children without BE.
Materials and Methods
Patient and control groups
Children were recruited from the Royal Children’s Hospital in Brisbane and the Royal Darwin
Hospital. The study was approved by the Institutional Ethics Committee from both hospitals
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and written informed consent obtained from each parent or carer. Inclusion criteria included
the diagnosis of BE. Aged matched control children were undergoing bronchoscopy with no
history of chronic cough or wheeze eg., evaluation of stridor or re-evaluation of structural air-
way abnormality. Exclusion criteria included a clinical history of primary aspiration (coughs or
chokes with at least every second feed), neuromuscular problems, primary adaptive immunity
abnormality, past history of invasive infections (meningitis etc), recurrent (>2) pneumonia
and other respiratory disease. All children had a standardized medical history taken with a
focus on respiratory history including cough quality (wet/dry) [17]. Demographics collected
included possible contributors to frequency of respiratory infections (day care attendance,
smoke exposure, number of siblings in house-hold, socioeconomic status, vaccinations and
recent use of antibiotics). Sweat test for exclusion of cystic fibrosis was performed as well as spi-
rometry for those aged>4 years. Blood and BAL was obtained during bronchoscopy (per-
formed routinely under general anesthesia) [18] and microbiology determined on BAL. All
children were in stable state (ie no current exacerbation) when the specimens were collected.
We investigated respiratory bacteria and viruses of clinical significance in the BAL of children
in this study, including mycoplasma, influenza, Adenovirus, Strep. pneumoniae, Staph aureus,
Moraxella catatthalis, Pseudomonas aeruginosa andH. influenzae.
Leukocyte numbers in peripheral blood and BAL
Full blood counts, including white cell differential counts, were determined on blood speci-
mens using a CELL-DYN 4000 (Abbot Diagnostics, Sydney, Australia). BAL cell counts were
determined using a haemocytometer. Blood films and BAL cytospins were stained by the May-
Grunwald-Giemsa method and white cell differential counts checked by morphological assess-
ment microscopically.
CD4/CD8 T, NKT-like and NK cell percentages
CD4 and CD8 T, NKT-like and NK cell percentages in blood and BAL were enumerated as
previously reported using flow cytometry [11–13].
Perforin and granzyme b expression in T, NKT-like and NK cells
Expression of perforin and granzyme b was also determined in T, NKT-like and NK cells as
previously reported [11–13]. Briefly, BAL was centrifuged 300 ×g for 5 min and cells re-sus-
pended at 5x105 mL in RPMI 1640 medium (Gibco, New York, USA) supplemented with 125
U/mL penicillin and 125 U/mL streptomycin (Gibco). Aliquots of 150 μL blood and 100 μL
BAL were added to 2 mL FACSLyse (BD Biosciences, Sydney, Australia) for 10 min at room
temperature. Cells were then centrifuged 300 ×g for 5 min and the cell pellet re-suspended in
0.5 mL FACSPerm (BD) for 10 min at room temperature. Two mL 0.5% bovine serum albumin
(Sigma/Aldrich, Sydney, Australia) / Isoflow (Beckman Coulter, Sydney, Australia) was then
added and the tubes centrifuged at 300 ×g for 5 min. Five μL of appropriately diluted anti- per-
forin FITC (eBioscience, Sydney, Australia), CD3 perCP.CY5.5 (BD), CD4 PE.CY7 (BD),
CD56 APC (Beckman Coulter, Sydney, Australia), CD8 APC.CY7 (BD), granzyme b V450
(BD) and CD45 V500 (BD) monoclonal antibodies were added for 15 min in the dark at room
temperature for 15 min. Two mL of 0.5% bovine serum albumin (Sigma) / Isoflow (Beckman
Coulter) was then added and the tubes centrifuged at 300 × g for 5 min. After decanting, cells
were analyzed within 1 h on a FACSCanto II flow cytometer using FACSDiva software (BD).
Samples were analyzed by gating lymphocytes using CD45 staining versus side scatter (SSC). A
minimum of 350,000 low SSC events for blood and 50,000 low SSC events for BAL were
acquired in list-mode format for analysis. T cells were identified as CD3+CD56-CD45+ low
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FSC/SSC events, NKT-like cells were identified as CD3+CD56+CD45+ low FSC/SSC events
and NK cells as CD3-CD56+ CD45+ low FSC/SSC events. Results are expressed as a percentage
of lymphocytes.
IFNγ and TNFα production by T, NKT-like and NK cells
Production of IFNγ and TNFα by T, NKT-like and NK cells was determined on blood and
BAL samples from all subjects as previously reported [11–13].
Briefly, one mL blood diluted 1:2 in RPMI and prepared BAL cells were stimulated with
phorbol myristate (25 ng/mL) (Sigma, Sydney, Australia) and ionomycin (1 μg/mL) (Sigma).
Brefeldin A (10 μg/mL) was added as a “Golgi block” (Sigma) and the tubes re-incubated in a
humidified 5% CO2/95% air atmosphere at 37°C for 16 h. Aliquots of blood and BAL were
added to FACS tubes (BD) and treated with FACSLyse and FACSPerm as above and five μL of
appropriately diluted anti- IFNγ FITC (BD), CD3 perCP.CY5.5 (BD), CD56 APC (Beckman
Coulter, Sydney, Australia), CD8 APC.CY7 (BD), TNFα V450 (BD) and CD45 V500 (BD)
monoclonal antibodies were added for 15 min in the dark at room temperature. Two mL of
0.5% bovine serum albumin (Sigma) / Isoflow (Beckman Coulter) was then added and the
tubes centrifuged at 300 ×g for 5 min. After decanting, cells were analyzed as above.
Statistical Analysis
Power analysis was performed based on our previous studies (eg, n = 12 allows a power of 92%
to detect a 20% increase in perforin production by T-cells in peripheral blood). Statistical anal-
ysis was performed using the Mann-Whitney test. Bivariate correlation analyses between cell
types, inflammatory/cytotoxic markers and Indigenous status, age, gender and viral/bacterial
isolation from BAL, were performed using Spearman Rho correlation tests. SPSS software was
applied and differences between groups of p<0.05 considered significant.
Results
Demographic details of subjects
The demographic details of the children studies are presented in Table 1. There were no signifi-
cant differences in gender between groups. The BE group contained more Indigenous children
compared to controls. There were non-significant trends (p = 0.069 and p = 0.079 respectively)
for increased percentages of neutrophils in BAL and blood from children with BE compared to
controls (Table 1).
Organisms identified in BAL of children
Adenovirus was detected in BAL from 1 control and 1 child with BE, and RSV from one child
with BE (Table 1). There was a range of organisms isolated from the BAL of both patient and
control groups including Streptococcus pneumonia, Staphylococcus aureus, Pseudomonas aeru-
ginosa andMoraxella catarrhalis. NTHi was detected from 50% of the children with BE vs.
10% of controls. Overall, the median (iq 1,3) number of organisms (power of 10 cfu/mL) for
control children was 3.5 (3,4), and 4.00 (3,4) for children with BE, and no significant difference
between the groups was noted (Table 1).
CRP levels in blood
There were no differences in CRP levels between patient and control groups (Table 1).
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T, NKT-like and NK cell percentages
There was a significant increase in CD8+ T cells in the blood of children with BE compared
with controls but no other differences in the percentages of T, CD4+T cells, NKT-like or NK
cells in blood or BAL between groups (as a percentage of CD45+ lymphocytes) (Table 2).
Perforin and granzyme b expression in T, NKT-like and NK cells
There was a significant increase in the percentages of T and NKT-like cells expressing gran-
zyme b and perforin in the blood of children with BE compared with controls (Fig 1) but no
difference in the percentage of NK cells expressing granzyme b and perforin between groups
(granzyme b: 78.0±17.3 (74.3±11.2), perforin: 81.0±13.4 (86.7±10.3) for BE (Controls) respec-
tively p>0.05 for all).
There was no significant differences in the percentages of T, NKT-like or NK cells express-
ing granzyme b or perforin in the BAL of children with BE compared with controls (Table 3).
Table 1. Demographic details of the children tested.
Controls Bronchiectasis
N 10 12
Age (months) 40 (19.5,83.3) 36 (27.82.5)
Gender (M/F) 7/3 5/7
Indigenous (Y/N) 1/9 6*/6
Blood WCC (x109/L) 8.1 (7.3,10.0) 9.3 (8.2,11.0)
BAL WCC (x106/L) 200 (126,234) 265 (152,360)
Blood neutrophils 2.5 (2.1,2.7) 3.2 (2.7,3.6)
CRP 2.0 (2,2) 2.0 (2,2)
BAL neutrophils 5.5 (2.8,8.0) 12.25 (6.8,25)
Mycoplasma (n) 0 0
Inﬂuenza (n) 0 0
RSV (n) 0 1
Adenovirus (n) 1 1
Power of 10 Bacteria cfu/mL) 3.5 (13,4) 4.0 (3,4)
*p<0.05 vs. control.
Data presented as median (q1, q3) unless otherwise indicated. N, number; WCC, total leucocyte count; BAL, bronchoalveolar lavage ﬂuid; RSV,
Respiratory syncytial virus; cfu, colony forming units.
doi:10.1371/journal.pone.0133695.t001
Table 2. The percentages of T, CD8+T, NKT-like and NK cells in the blood and BAL of children with bronchiecstasis (BE) and controls. Data pre-
sented as median (q1, q3) unless otherwise indicated. There was a significant increase in the percentage of CD8+T cells in the blood of children with BE com-
pared with control group (p = .010).
T CD8 NKT-like NK
Blood Control 73.5 (70.5,83.5) 25 (23,32) 1 (1,4) 6 (3,10)
BE 84.5 (69.3,88) 38 (31,48)* 2 (1,3) 9 (6,16)
BAL Control 79.9±12.6 63.5±14.9 6.3±3.8 5.9±4.1
BE 80.9±13.1 53.0±13.6 7.7±6.5 4.1±2.9
*p<0.05 vs. control.
doi:10.1371/journal.pone.0133695.t002
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IFNγ and TNFα production by T, NKT-like and NK cells
There was a significant increase in the percentages of T cells producing IFNγ and TNFα, NKT-
like cells producing IFNγ (trend for TNFα) and NK cells producing IFNγ (trend for TNFα) in
the blood of children with BE compared with controls (Fig 2).
There was no significant differences in the percentages of T, NKT-like or NK cells produc-
ing IFNγ and TNFα in the BAL of children with BE compared with controls (Table 4).
Fig 1. The percentages of T (CD3) and NKT-like (CD3.56) cells expressing granzyme b (GB) and perforin (PER) in the blood of children with BE
(grey bars) compared with controls (clear bars). There was a significant increase in the percentages of T and NKT-like cells expressing granzyme b and
perforin in the blood of children with BE compared with controls.
doi:10.1371/journal.pone.0133695.g001
Table 3. The percentages of T, NKT-like or NK cells expressing granzyme b (GB) and perforin (PER) in the BAL of children with BE compared with
controls. There was no differences in the percentages of T, NKT-like or NK cells expressing granzyme b or perforin in the BAL of children with BE compared
with controls (p>0.05 for all).
T NKT-like NK
GB PER GB PER GB PER
Control 4.5±12.6 1.1±0.7 8.1±2.9 3.3±2.2 3.6±2.9 1.7±0.9
BE 3.6±12.6 1.3±0.8 6.2±3.7 4.8±3.1 3.6±2.6 1.3±0.8
doi:10.1371/journal.pone.0133695.t003
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Perforin/granzyme b expression and IFNγ/TNFα production in T, NKT-
like and NK cells from Indigenous and non-Indigenous children with BE
To elucidate any differences in cytotoxic or pro-inflammatory lymphocyte subsets between
Indigenous and non-Indigenous children with BE, we analysed granzyme b and perforin
expression and IFNγ and TNFα production in lymphocyte subsets from these patient groups.
There was a significant increase in the expression of granzyme b and perforin in T cells
from Indigenous children with BE compared with non-Indigenous children (Fig 3). There was
a significant increase in the percentage of T cells producing IFNγ (trend for TNFα) from Indig-
enous children with BE compared with non-Indigenous children (Fig 3).
Fig 2. The percentages of T (CD3) and NKT-like (CD3.56) and NK cells (CD56) producing IFNγ and TNFα in the blood of children with BE (grey bars)
compared with controls (clear bars). There was a significant increase in the percentages of T cells producing IFNγ and TNFα, NKT-like cells producing
IFNγ (trend for TNFα) and NK cells producing IFNγ (trend for TNFα) in the blood of children with BE compared with controls.
doi:10.1371/journal.pone.0133695.g002
Table 4. The percentages of T, NKT-like or NK cells producing IFNγ and TNFα in the BAL of children with BE compared with controls There was no
significant differences in the percentages of T, NKT-like or NK cells producing IFNγ and TNFα in the BAL of children with BE compared with con-
trols (p>0.05 for all).
T NKT-like NK
IFNγ TNFα IFNγ TNFα IFNγ TNFα
Control 25.5±8.5 24.2±9.3 33.7±10.1 29.0±7.8 11.8±6.6 14.8±7.7
BE 21.8±7.4 22.3±8.3 28.9±9.9 21.9±11.2 11.7±5.4 14.1±7.8
doi:10.1371/journal.pone.0133695.t004
Inflammation in Children with Bronchiectasis
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There were no differences in the percentages of NKT-like or NK cells expressing granzyme
b or perforin or producing IFNγ and TNFα in the blood of Indigenous children with BE com-
pared with non-Indigenous children (p>0.05 for all) (data not shown). There were no differ-
ences in the percentages of NKT-like or NK cells expressing granzyme b or perforin or
producing IFNγ and TNFα in the BAL of Indigenous children with BE compared with non-
Indigenous children (p>0.05 for all) (data not shown). Representative flow cytometry plots of
T cells expressing granzyme b and perforin and producing IFNγ and TNFα in the blood of
Indigenous children with BE compared with non-Indigenous children with BE is shown in
Fig 4.
Bivariate correlation analysis
There were no significant associations between gender, age, Indigenous status, NTHi or adeno-
virus in BAL, T-cell numbers, and any of the inflammatory/cytotoxic parameters tested. A pos-
itive correlation was noted between S. pneumoniae isolation from BAL, and IFN-g and TNF-a
production by T-cells (correlation coefficients .437 and .407; p = 0.033 and.049 respectively)
and with NKT-cell production of IFN-g (correlation coefficients .460 p = 0.024). The percent-
age of CD8+ T-cells in blood correlated positively with T-cell production of both IFN-g and
TNF-a (correlation coefficients .504 and .423; p = 0.010 and.040 respectively). NK numbers
correlated with T-cell expression of perforin, granzyme b, IFN-g and TNF-a (correlation coeffi-
cients .505, .496, .460,.540; p = 0.014, 0.016,0.021,0.006 respectively). Numerous significant
correlations were noted between the various inflammatory/cytotoxic mediators tested
(Table 5).
Discussion
This is the first study to show that childhood BE is associated with increased peripheral blood
cytotoxic and pro-inflammatory T, NKT-like and NK cells. The groups of children included in
Fig 3. The percentages of T (CD3) expressing granzyme b (GB) and perforin (PER) and T cells
producing IFNγ and TNFα in the blood of Indigenous children with BE (grey checkered bars)
compared with non-Indigenous children with BE (grey bars). There was a significant increase in the
percentages of T cells expressing granzyme b and perforin in the blood of Indigenous children with BE
compared with non-Indigenous children with BE. There was a significant increase in the percentage of T cells
producing IFNγ (trend for TNFα), in the blood of Indigenous children with BE compared with non-Indigenous
children with BE.
doi:10.1371/journal.pone.0133695.g003
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the present study characteristically have a high rate of generational cultural diversity; thus,
determination of the influence of Indigenous status on the systemic immune response is diffi-
cult. Despite this, we found that children in the BE group that were identified by their parent as
having Indigenous Australian ancestry, had a further increase in cytotoxic pro-inflammatory T
cells in the peripheral blood compared with non-Indigenous children with BE. A potential lim-
itation of this study is that a comparison between affected children and control children with
the same ethnic component was not possible. However, our previous extensive investigations
have shown that Indigenous status in children with lung disease has no significant effect with
regards to systemic inflammation, suggesting that the differences noted in BE between Indige-
nous and non-Indigenous populations were not influenced by systemic inflammation. In a pre-
vious investigation of children with BE involving Indigenous and non-Indigenous children, we
found that, using regression analysis, Indigenous descent was not an independent predictor of
IFN-γ production [19]. We have also found that high pulmonary expression of IL-6 and IL-1β
in children with chronic suppurative lung disease is associated with impaired recall responses
to non-typeable Haemophilus influenzae (unpublished data: manuscript under consideration),
Our analyses also found no difference between Indigenous and non-Indigenous children with
respect to the degree of systemic inflammation measured by levels of IL-6, IL-8 and CRP.
These novel findings of increased systemic cytotoxic pro-inflammatory T cells in children with
Fig 4. Representative flow cytometry plots of T cells (CD3+CD56) expressing granzyme b and perforin
and producing IFNγ and TNFα in the blood of Indigenous children with BE compared with non-
Indigenous children withy BE. There was a significant increase in the expression of granzyme b and
perforin in T cells from Indigenous children with BE compared with non-Indigenous children. There was a
significant increase in the percentage of T cells producing IFNγ (trend for TNFα) from Indigenous children
with BE compared with non-Indigenous children.
doi:10.1371/journal.pone.0133695.g004
Inflammation in Children with Bronchiectasis
PLOS ONE | DOI:10.1371/journal.pone.0133695 August 10, 2015 9 / 13
T
ab
le
5.
B
iv
ar
ia
te
an
al
ys
is
o
fc
o
rr
el
at
io
n
s
b
et
w
ee
n
in
fla
m
m
at
o
ry
/c
yt
o
to
xi
c
m
ed
ia
to
rs
in
b
lo
o
d
.
N
K
T
N
K
P
er
fo
ri
n
T
P
er
fo
ri
n
N
K
T
P
er
fo
ri
n
N
K
IF
N
γ
T
IF
N
γ
N
K
T
IF
N
γ
N
K
T
N
F
α
T
T
N
F
α
N
K
T
T
N
F
α
N
K
G
ra
nz
ym
e
b
T
0.
24
1
(0
.2
68
)
0.
48
6
(0
.0
19
)*
0.
77
1
(0
.0
01
)*
0.
20
3
(0
.3
53
)
0.
63
1
(0
.1
06
)
0.
40
5
(0
.0
63
)
0.
48
2
(0
.0
27
)*
0.
37
9
(0
.0
90
)
0.
52
5
(0
.0
15
)*
0.
55
0
(0
.0
10
)*
0.
44
9
(0
.0
41
)*
G
ra
nz
ym
e
b
N
K
T
0.
30
9
(0
.1
51
)
0.
07
4
(0
.7
36
)
0.
20
7
(0
.3
42
)
0.
32
6
(0
.1
29
)
0.
65
4
(0
.0
01
)*
0.
12
3
(0
.5
66
)
0.
23
0
(0
.3
15
)
0.
40
1
(0
.0
72
)
0.
13
0
(0
.5
73
)
0.
23
1
(0
.3
13
)
0.
43
9
(0
.0
46
)*
G
ra
nz
ym
e
b
N
K
0.
26
7
(0
.2
17
)
0.
33
7
(0
.1
16
)
0.
55
1
(0
.0
06
)*
0.
75
6
(0
.0
00
)*
0.
42
8
(0
.0
42
)*
0.
26
9
(0
.2
27
)
0.
50
3
(0
.0
20
)*
0.
51
8
(0
.0
16
)*
0.
17
7
(0
.4
42
)
0.
43
4
(0
.0
49
)*
0.
66
0
(0
.0
01
)*
D
at
a
pr
es
en
te
d
as
P
ea
rs
on
C
or
re
la
tio
n
co
ef
ﬁ
ci
en
t(
p
va
lu
e.
(2
-t
ai
le
d)
).
*S
ig
ni
ﬁ
ca
nt
co
rr
el
at
io
ns
ar
e
hi
gh
lig
ht
ed
in
bo
ld
.
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
33
69
5.
t0
05
Inflammation in Children with Bronchiectasis
PLOS ONE | DOI:10.1371/journal.pone.0133695 August 10, 2015 10 / 13
BE, independent of Indigenous status, identifies an up-regulated systemic adaptive immune
response and may reflect a more severe disease when BE is diagnosed [1].
Up to 50% of subjects with COPD have evidence of BE on computer tomography scanning
[20]. Like COPD, BE has been shown to be associated with increases in systemic markers of
inflammation and we hypothesized that we may elucidate similar findings in childhood BE,
particularly in Indigenous children where BE is often more severe [1]. However, the systemic
inflammation and pathogenic mechanisms that are present in the children with BE are likely to
be very different to the systemic inflammation present in COPD. Although COPD is some-
times associated with BE in older adults (who also have cardiovascular comorbidities), COPD
is a disease which manifests in older adults, who are likely to have altered immunological
responses due to aging and smoking. Contributors to the systemic inflammation in children
with BE may include a larger proportion of these children who had been exposed to cigarette
smoke (66%) compared to control children (25%), recurrent lower respiratory tract infections
and colonisation of the airway with microbes including S. pneumoniae and non-typeable H.
influenza. In this regard we found that NTHi was isolated from 50% of the children with BE vs.
10% controls, and that there was a significant correlation between the presence of S. pneumo-
niae in BAL and the production of TNF-alpha and IFN-gamma by T and NKT-like cells in the
children with BE.
Systemic changes noted in chronic lung disease have been suggested to result from a spill-
over of inflammatory lymphocytes from the lung [21]. In this regard we have previously shown
increased pro-inflammatory T, NKT-like and NK cells in the airways (BAL derived), peripheral
blood and intraepithelial cells (bronchial brushings derived) from adults with chronic lung dis-
eases including COPD and bronchiolitis obliterans syndrome following lung transplantation
[12–15]. Interestingly, although we found similar changes in cytotoxic/pro-inflammatory lym-
phocyte subsets in the peripheral blood in children with BE, we did not detect these changes in
the BAL, reflecting potentially different immunological response in patients with BE compared
with COPD, although the possibility of a type II error due to BAL numbers cannot be excluded.
There has been a report of increased activated CD8+ T cells infiltrating the bronchial wall
below the basement membrane in adult patients with BE [20]. As such, a further study examin-
ing the cytotoxic/pro-inflammatory profile of intra-epithelial lymphocytes obtained by bron-
chial brushings from children with BE, as we have previously done for COPD patients, could
prove enlightening [12,13].
There have been reports of elevated WCC, CRP, fibrinogen levels and bacterial colonization,
suggesting the presence of a systemic inflammatory response, in clinically stable adult BE
patients [22]. To our knowledge this is the first report of elevated systemic lymphocyte markers
in childhood BE and raises the question of whether these cells that are active early on in life,
are the instigators of co-morbid diseases prevalent in this patient group, later on in life. In this
regard, cytotoxic pro-inflammatory CD8+ T and NK cells have been shown to be associated
with atherosclerosis and osteoporosis in adults [23–25]. Although there was no correlation
between the percentage of lymphocyte subsets expressing cytotoxic/pro-inflammatory media-
tors and other markers of systemic inflammation such as WCC, CRP or circulating neutrophil
levels, this may be reflective of the age of the study group and disease duration and other mark-
ers such as ESR, hsCRP and HR-CT score may have proven useful and would be a worthwhile
addition to future studies.
We and others have shown a correlation between soluble and T cell expression of TNFα
and lung function as measure by forced expiry volume in one second (FEV1) in adult patients
with COPD [12,24]. TNFα has been described as the possible driving force behind COPD [26].
The report that high plasma concentrations of TNFα were associated with severity of BE in
clinically stable adult [16] patients may also suggest a possible role of TNFα in the pathogenesis
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of BE and longitudinal monitoring of lymphocyte subset pro-inflammatory profiles may be a
useful tool in assessing severity of BE in patients [16].
In conclusion, childhood BE in is associated with increased systemic pro-inflammatory/
cytotoxic T cells in the peripheral blood. While strategies that target these pro-inflammatory/
cytotoxic cells might conceivably reduce future co-morbidities in these patients, further
research needs to be done to more fully understand inflammation in BE.
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